Introduction
Cell therapy is a type of therapy in which live cells are injected into a patient for the treatment of a number of disorders. It involves the administration of somatic cell preparations for the treatment of diseases or traumatic damages.
The cell therapy market is anticipated to witness healthy growth due to the increasing prevalence of chronic conditions, rising adoption of regenerative medicine, and rise in the number of clinical studies about the development of cellular therapies.
The COVID-19 pandemic has severely impacted healthcare industry. During this period, most of the companies have been focusing on the development of cell-based therapies for COVID-19 treatment. Also, most of the pharmaceutical, biotechnology, and research institutes have been focusing on the development of cell therapy-based treatment against COVID-19.
Table of Contents
Executive Summary
Scope of the report
Research Methodology
Executive Summary
Introduction
5.1 Parent Market/ TAM
5.2 Market Outline
5.3 Market Segmentation
6.Five Force analysis
7.Market Sizing
8.Market segmentation
9.Geographical Landscape
9.1 APAC
9.2 Europe
9.3 North America
9.4 ROW
10.Growth drivers
10.1 Rise in number of clinical studies for cellular therapies
10.2 Growing adoption of regenerative medicine
11.Key Market Trends
12.Impact of Covid-19
13.Challenges
14.Customer Insights analysis
15.Major Market Players
15.1 Kolon TissueGene
15.2 Anterogen Co.
15.3 JCR Pharmaceuticals Co.
15.4 Castle Creek Biosciences
15.5 MEDIPOST
15.6 Osiris Therapeutics
15.7 NuVasive
15.8 Vericel Corporation
15.9 PHARMICELL
15.10 Bristol-Myers Squibb Company
16.Recent Developments
17.Future Scope
18.Strategic Recommendations
Market Overview
The global cell therapy market is expected to grow to $7.87 billion by 2025
Growth momentum is expected to accelerate during the forecast period with a 14.96% CAGR.
Increasing financing and investments to support the launch of new companies are expected to boost organic revenue growth of the market.
North America is dominating the market due to the presence of a substantial number of centers and institutes that are engaged in R&D pertaining to stem cell therapy.
Key Trends
The surge in a number of regulations to promote stem cell therapy is expected to boost the growth of the market.
The increasing funds for research in developing countries are expected to offer lucrative opportunities for the market near future.
Key Market Players
Some of the key players in the market are Kolon TissueGene, Anterogen Co., JCR Pharmaceuticals Co., Castle Creek Biosciences, MEDIPOST, Osiris Therapeutics.
The key players are evolving through various strategies such as investment in research and development, acquisitions, partnerships, and collaboration to secure the market position.
Growth Drivers and Challenges
The rise in number of clinical studies for cellular therapies is the key driving factor of the market
The growing adoption of regenerative medicine is also driving the market growth
Implementation of stringent government regulations is hindering the market growth
Clinical issues pertaining to development & implementation of cell therapy is also restraining the market growth.